Follow us for updates
© 2022
Read the Story →

By 2023, Duterte Says Philippines Can Return to Normal with Vaccines

He replied to a question.
Feb 28, 2021
Photo/s: Sen. Bong Go

President Rodrigo Duterte said Sunday the Philippines could return to "normal" by early 2023, as he received the first COVID-19 vaccine shipments, courtesy of China.

Duterte was asked during a press briefing to forecast when the Philippines could return to "normal." He prefaced his answer with a commitment to rollout as many vaccines the fastest that he can.

"In about, maybe early, year 2023, not 2022," Duterte said.

"Ito ngayon, hanggang katapusan ng buwan, paspasan tayo. Early in the first or second quarter of 2023, baka, sa tulong ng Diyos," he said.


With Vaccines, Duterte Says Economy Can Reopen, Face-to-Face Classes Can Wait

What to Expect: Philippines to Deliver First COVID Vaccine Shots

Duterte said the vaccination program would enable more people to return to work, reviving the economy that was mired in its deepest recession since World War II.

Continue reading below ↓

"Our economy is really down, as in down, so the earlier mabilisan itong vaccine, the better," he said.

"Pag nag-umpisa na yang rollout and the other vaccines, and distribution to the provinces, I may, siguro pagdating nga mga... we'll have a million by this month. Magkakaroon tayo ng stock na two million, bitawan ko na. I will open the economy," he said.

Continue reading below ↓
Recommended Videos
Latest Headlines
Read Next
Recent News
Foreign money converted to Peso.
Meta says it was referring to a different "Live Shopping" feature.
With the reopening of several local destinations, this app has never been more timely.
The virus is also found in shrews.
After four people drowned in their basement apartment.
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to newsletter, you agree to our Terms of Service and Privacy Policy.